E H Cooper
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- Bone health and treatments
- Nephrology top 5%
Papers in
- Oncology 17
- Lung Cancer Research Studies 7
- Colorectal Cancer Treatments and Studies 3
- Bone health and treatments 3
- Epidemiology 11
- Neuroendocrine Tumor Research Advances 9
- Co-authors
- M A Forbes (3 shared papers)John G. Raynes (1 shared paper)Michael McMahon (2 shared papers)Hai Yu (1 shared paper)R A Crockson (1 shared paper)A. Mayer (1 shared paper)Yukio Yanagisawa (1 shared paper)I. C. M. Maclennan (1 shared paper)
- Journals
- British Journal of Cancer (10 papers)Journal of Clinical Pathology (3 papers)Clinical Chemistry (2 papers)Nephrology Dialysis Transplantation (2 papers)The International Journal of Biological Markers (2 papers)
- Partner nations
- United KingdomDenmarkNetherlands
In The Last Decade
E H Cooper
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Oncology 437
- Nephrology 101
- Neurology 96
- Hematology 73
- Orthopedics and Sports Medicine 51
Countries citing papers authored by E H Cooper
This map shows the geographic impact of E H Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E H Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E H Cooper more than expected).
Fields of papers citing papers by E H Cooper
This network shows the impact of papers produced by E H Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E H Cooper. The network helps show where E H Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside E H Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 160 | |
| 2 | 1984 | 108 | |
| 3 | 1985 | 102 | |
| 4 | 1994 | 86 | |
| 5 | 1994 | 85 | |
| 6 | 1983 | 74 | |
| 7 | 1989 | 57 | |
| 8 | 1993 | 56 | |
| 9 | Activity of JM9 in advanced ovarian cancer: a phase I-II trial. | 1985 | 55 |
| 10 | 1990 | 45 | |
| 11 | 1988 | 42 | |
| 12 | 1994 | 31 | |
| 13 | 1988 | 27 | |
| 14 | 1961 | 26 | |
| 15 | 1994 | 22 | |
| 16 | 1989 | 21 | |
| 17 | 1991 | 21 | |
| 18 | 1991 | 21 | |
| 19 | 1988 | 20 | |
| 20 | 1992 | 17 |
About E H Cooper
E H Cooper is a scholar working on Oncology, Epidemiology, Molecular Biology, Surgery and Neurology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (7 papers), Glycosylation and Glycoproteins Research (6 papers), Neuroblastoma Research and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Pancreatitis Pathology and Treatment (3 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Oncology (437 citations), Nephrology (101 citations), Neurology (96 citations), Hematology (73 citations) and Orthopedics and Sports Medicine (51 citations). E H Cooper has collaborated with scholars based in United Kingdom, Denmark and Netherlands. Frequent co-authors include M A Forbes, John G. Raynes, Michael McMahon, Hai Yu, R A Crockson, A. Mayer, Yukio Yanagisawa, I. C. M. Maclennan, Heine H. Hansen and Lone Jørgensen. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Pathology, Clinical Chemistry, Nephrology Dialysis Transplantation and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.